|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1301 CONNECTICUT AVENUE, NW, #700 |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip Code | 20036 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 738-12
|
||||||||
|
6. House ID# 303180000
|
||||||||
| TYPE OF REPORT | 8. Year | 2026 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Kelly Baden |
Date | 7/20/2026 3:41:13 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY 27 Appropriations- Emailed Senate offices to sign on to FY 27 international family planning/reproductive health
- Signed on to a FY 27 appropriations letter urging the House to support reproductive health and rights priorities
- Signed on to a FY 27 appropriations letter to the House supporting funding for domestic family planning programs
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Samira |
Damavandi |
|
Senior Federal Policy Associate |
|
Anna |
Bernstein |
|
Principal Federal Policy Advisor |
|
Amy |
Friedrich-Karnik |
|
Director of Federal Policy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
-Standing call with Senate staff on reproductive health and rights issues
-H.R. 4611- The EACH Act- urged House and Senate offices to cosponsor the bill
-H.Res.1389 Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care- met with staff and drafted text
-Reproductive Health Travel Fund Act (not yet introduced)- worked on drafting text
-S.Res.732 / H.Res.1285 Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. Reviewed and endorsed legislation
-S.4701 Freedom to Travel for Health Care Act of 2026- Reviewed and endorsed legislation
- Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation
- H.R.9470 SAFER Health Act- Reviewed and endorsed legislation
- S.4701 Freedom to Travel for Health Care Act of 2026- Made social media in support of bill, social media content development
-S. 4922- Reproductive Health Travel Fund Act of 2026- social media content development
- H.R. 9441- SAFE Training for OBGYNs Act- Endorsed legislation
- HR 999 Right to Contraception Act- Supported discharge petition
- Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff to discuss bill reintroduction
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Anna |
Bernstein |
|
Principal Federal Policy Advisor |
|
Samira |
Damavandi |
|
Senior Federal Policy Associate |
|
Noli |
Vega |
|
Senior Digital Communications Manager |
|
Amy |
Friedrich-Karnik |
|
Director of Federal Policy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
-Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff from Rep. Schakowsky's offices to discuss reintroduction of bill
-H.R 8582/ S. 4426- Protecting Human Rights and Public Health in Foreign Assistance Act- Endorsed bill, emailed staff to cosponsor bill, social media content and development, met with colleagues to discuss advocacy strategies
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Samira |
Damavandi |
|
Senior Federal Policy Associate |
|
Amy |
Friedrich-Karnik |
|
Director of Federal Policy |
|
Noli |
Vega |
|
Senior Digital Communications Manager |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
- Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation
- H.R.9470 SAFER Health Act- Reviewed and endorsed legislation
- HR 999 Right to Contraception Act- Supported discharge petition
- S.4701 Freedom to Travel for Health Care Act of 2026- social media content development
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Anna |
Bernstein |
|
Principal Federal Policy Advisor |
|
Amy |
Friedrich-Karnik |
|
Director of Federal Policy |
|
Noli |
Vega |
|
Senior Digital Communications Manager |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |